 BOULDER, Colo.--BUSINESS WIRE--- BDSX patientsfirst--Biodesix, Inc. Nasdaq: BDSX, a leading data-driven diagnostic solutions company, today announced that multiple data presentations will occur at the 2021 annual CHEST virtual conference. Presentations will include newly emerging data from the post-market, prospective, real-world ORACLE study An Observational Registry Study to Evaluate the Performance of the Nodify XL2 Test - ORACLE NCT03766958, demonstrating that incorporation of this blood-based test in t 